Physician profile
Brandon Taylor
NPI 1285855106
$1,650.23
in general payments reported to CMS, 2019-2025
18 companies · $52.70 in 2025
The $52.70 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2020: $173 · 2021: $401 · 2022: $379 · 2023: $354 · 2024: $125 · 2025: $52.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $531.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $314.76 | 2021-2024 | Qelbree, Qelbree |
| Pfizer INC. | $183.08 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $173.16 | 2020-2024 | Vaxneuvance, Gardasil 9, M-M-R II |
| Takeda Pharmaceuticals U.S.A., INC. | $168.62 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $118.44 | 2019-2023 | Jornay Pm |
| Glaxosmithkline, LLC. | $109.05 | 2021-2023 | Bexsero |
| Sanofi Pasteur INC. | $95.75 | 2019-2023 | |
| Organon LLC | $84.97 | 2021-2022 | |
| Corium, LLC | $82.60 | 2022-2025 | Azstarys |
| Sobi, INC | $64.59 | 2020-2022 | |
| Tris Pharma INC | $60.73 | 2021-2025 | Onyda Xr |
| Biomerieux INC | $45.73 | 2023-2024 | Biofire Spotfire Respiratory (R) Panel |
| Arbor Pharmaceuticals, INC. | $37.58 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $28.77 | 2023 | Flumist Quadrivalent |
| Adlon Therapeutics L.P. | $27.84 | 2020-2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ptc Therapeutics, INC. | $25.48 | 2023 | |
| Biogen, INC. | $14.84 | 2024 | Spinraza |
| Sanofi-Aventis U.S. LLC | $14.24 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.